Latest Articles

Publication Date
All News Scientific
Comparison of identification of sentinel lymph nodes between ICG vs methylene blue in v notes staging surgery for endometrial cancer - BMC Surgery

Comparison of identification of sentinel lymph nodes between ICG vs methylene blue in v notes staging surgery for endometrial cancer BMC Surgery

Published: Oct. 21, 2025, 11:10 a.m.
Read Full Article
New noninvasive endometriosis tests are on the rise - StartupNews.fyi

New noninvasive endometriosis tests are on the rise StartupNews.fyi

Published: Oct. 21, 2025, 10:28 a.m.
Read Full Article
New noninvasive endometriosis tests are on the rise - MIT Technology Review

New noninvasive endometriosis tests are on the rise MIT Technology Review

Published: Oct. 21, 2025, 10 a.m.
Read Full Article
Endogene.bio Study Validates Menstrual Blood Approach for Endometriosis Detection - Femtech Insider

Endogene.bio Study Validates Menstrual Blood Approach for Endometriosis Detection Femtech Insider

Published: Oct. 21, 2025, 8:12 a.m.
Read Full Article
Comparison of sociodemographic factors, lifestyle, and gastrointestinal symptoms between patients with endometriosis and IBS - BMC Gastroenterology

Comparison of sociodemographic factors, lifestyle, and gastrointestinal symptoms between patients with endometriosis and IBS BMC Gastroenterology

Published: Oct. 21, 2025, 7:07 a.m.
Read Full Article
‘Great first step’ – advocates react to new national endometriosis framework - The Irish Independent

‘Great first step’ – advocates react to new national endometriosis framework The Irish Independent

Published: Oct. 21, 2025, 4:30 a.m.
Read Full Article
Endometriosis rates double in 10 years, new research reveals - bodyandsoul.com.au

Endometriosis rates double in 10 years, new research reveals bodyandsoul.com.au

Published: Oct. 21, 2025, 1:04 a.m.
Read Full Article
What If We Took Endometriosis as Seriously as We Take Diabetes? - Women's eNews

What If We Took Endometriosis as Seriously as We Take Diabetes? Women's eNews

Published: Oct. 20, 2025, 6:42 p.m.
Read Full Article
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen - The AI Journal

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen The AI Journal

Published: Oct. 18, 2025, 10:28 a.m.
Read Full Article
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen - Business Wire

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen Business Wire

Published: Oct. 18, 2025, 10 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!